Amanta Healthcare reported FY26 revenue of ₹288 crore, a 5% YoY increase, with PAT surging 42% YoY to ₹15 crore.
Q4FY26 revenue grew 7% YoY to ₹77 crore, while PAT increased 28% YoY to ₹5.5 crore due to lower finance costs.
The company maintained FY26 EBITDA margins at 22% and announced ongoing capacity expansion for high-margin SteriPort and SVP products.
Management highlighted focus on scaling high-margin capacities, expanding domestic/export markets, and implementing operational efficiency initiatives.